Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1002/rth2.12080 http://scihub22266oqcxt.onion/10.1002/rth2.12080 C6055505!6055505!30046721     free     free     free Deprecated: Implicit conversion from float 217.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 217.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 217.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 217.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 217.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Res+Pract+Thromb+Haemost 2018 ; 2 (2): 188-98 Nephropedia Template TP {{tp|p=30046721|t=2018. The coagulation system in atherothrombosis: Implications for new therapeutic strategies |pdf=|usr=}}{{30046721}} gab.com Text The coagulation system in atherothrombosis: Implications for new therapeutic strategies JO: Res Pract Thromb Haemost http://www.kidney.de/pget.php?&tw=1&pmid=30046721 #FOAvip Essentials: A State of the Art lecture ?Clotting factors and atherothrombosis? was presented at the ISTH congress 2017.Coagulation proteins are not only involved in hemostasis, they also play a role in atherogenesis.Inhibition of coagulation proteins could potentially protect the vessel wall against progression of atherosclerosis.Combining antiplatelet and anticoagulant therapy has been demonstrated to improve cardiovascular outcomes in patients with stable atherosclerotic disease.Clinical manifestations of atherosclerotic disease include coronary artery disease (CAD), peripheral artery disease (PAD), and stroke. Although the role of platelets is well established, evidence is now accumulating on the contribution of coagulation proteins to the processes of atherosclerosis and atherothrombosis. Coagulation proteins not only play a role in fibrin formation and platelet activation, but also mediate various biological and pathophysiologic processes through activation of protease?activated?receptors (PARs). Thus far, secondary prevention in patients with CAD/PAD has been the domain of antiplatelet therapy, however, residual atherothrombotic risks remain substantial. Therefore, combining antiplatelet and anticoagulant therapy has gained more attention. Recently, net clinical benefit of combining aspirin with low?dose rivaroxaban in patients with stable atherosclerotic disease has been demonstrated. In this review, based on the State of the Art lecture ?Clotting factors and atherothrombosis? presented at the ISTH Congress 2017, we highlight the role of coagulation proteins in the pathophysiology of atherothrombosis, and specifically focus on therapeutic strategies to decrease atherothrombotic events by optimization of vascular protection. Twit Text FOAVip The coagulation system in atherothrombosis: Implications for new therapeutic strategies ????Res Pract Thromb Haemost http://www.kidney.de/pget.php?&tw=1&pmid=30046721 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=30046721 #FOAvip English Wikipedia <ref>{{Cite pmid|30046721}}</ref> The coagulation system in atherothrombosis: Implications for new therapeutic strategies #MMPMID30046721 Olie RH; van der Meijden PE; ten Cate H Res Pract Thromb Haemost 2018[Apr]; 2 (2): 188-98 PMID30046721show ga Essentials: A State of the Art lecture ?Clotting factors and atherothrombosis? was presented at the ISTH congress 2017.Coagulation proteins are not only involved in hemostasis, they also play a role in atherogenesis.Inhibition of coagulation proteins could potentially protect the vessel wall against progression of atherosclerosis.Combining antiplatelet and anticoagulant therapy has been demonstrated to improve cardiovascular outcomes in patients with stable atherosclerotic disease.Clinical manifestations of atherosclerotic disease include coronary artery disease (CAD), peripheral artery disease (PAD), and stroke. Although the role of platelets is well established, evidence is now accumulating on the contribution of coagulation proteins to the processes of atherosclerosis and atherothrombosis. Coagulation proteins not only play a role in fibrin formation and platelet activation, but also mediate various biological and pathophysiologic processes through activation of protease?activated?receptors (PARs). Thus far, secondary prevention in patients with CAD/PAD has been the domain of antiplatelet therapy, however, residual atherothrombotic risks remain substantial. Therefore, combining antiplatelet and anticoagulant therapy has gained more attention. Recently, net clinical benefit of combining aspirin with low?dose rivaroxaban in patients with stable atherosclerotic disease has been demonstrated. In this review, based on the State of the Art lecture ?Clotting factors and atherothrombosis? presented at the ISTH Congress 2017, we highlight the role of coagulation proteins in the pathophysiology of atherothrombosis, and specifically focus on therapeutic strategies to decrease atherothrombotic events by optimization of vascular protection. äThe coagulation system in atherothrombosis: Implications for new thera(epmc).pdf DeepDyve Pubget Overpricing